CD40LG and COVID-19: It was widely expected that during the COVID-19 outbreak, all patients would develop a primary type antibody response, characterized by the production of anti-SARS-CoV-2 IgM antibodies prior to anti-SARS-CoV-2 IgG and/or IgA antibody seroconversion.